ProteoTech, Inc. - Product Pipeline Review - 2014

  • ID: 2964596
  • Company Profile
  • 28 pages
  • Global Markets Direct
1 of 4
ProteoTech, Inc. - Product Pipeline Review - 2014

Summary

This, ‘ProteoTech, Inc. - Product Pipeline Review - 2014’, provides an overview of the ProteoTech, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ProteoTech, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of ProteoTech, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of ProteoTech, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the ProteoTech, Inc.’s pipeline products

Reasons to buy

- Evaluate ProteoTech, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of ProteoTech, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the ProteoTech, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of ProteoTech, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of ProteoTech, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of ProteoTech, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables
List of Figures
ProteoTech, Inc. Snapshot
ProteoTech, Inc. Overview
Key Information
Key Facts
ProteoTech, Inc. - Research and Development Overview
Key Therapeutic Areas
ProteoTech, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
ProteoTech, Inc. - Pipeline Products Glance
ProteoTech, Inc. - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
ProteoTech, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
ProteoTech, Inc. - Drug Profiles
DP-74
Product Description
Mechanism of Action
R&D Progress
PD-61W3
Product Description
Mechanism of Action
R&D Progress
PTI-110
Product Description
Mechanism of Action
R&D Progress
PTI-80
Product Description
Mechanism of Action
R&D Progress
PD-61-W3 Backup
Product Description
Mechanism of Action
R&D Progress
PTI-51CH3 Backup
Product Description
Mechanism of Action
R&D Progress
PTI-80 Backup
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit Islet Amyloid for Type 2 Diabetes
Product Description
Mechanism of Action
R&D Progress
ProteoTech, Inc. - Pipeline Analysis
ProteoTech, Inc. - Pipeline Products by Target
ProteoTech, Inc. - Pipeline Products by Route of Administration
ProteoTech, Inc. - Pipeline Products by Molecule Type
ProteoTech, Inc. - Pipeline Products by Mechanism of Action
ProteoTech, Inc. - Recent Pipeline Updates
ProteoTech, Inc. - Dormant Projects
ProteoTech, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
ProteoTech, Inc., Key Information
ProteoTech, Inc., Key Facts
ProteoTech, Inc. - Pipeline by Indication, 2014
ProteoTech, Inc. - Pipeline by Stage of Development, 2014
ProteoTech, Inc. - Monotherapy Products in Pipeline, 2014
ProteoTech, Inc. - Phase I, 2014
ProteoTech, Inc. - Preclinical, 2014
ProteoTech, Inc. - Pipeline by Target, 2014
ProteoTech, Inc. - Pipeline by Route of Administration, 2014
ProteoTech, Inc. - Pipeline by Molecule Type, 2014
ProteoTech, Inc. - Pipeline Products by Mechanism of Action, 2014
ProteoTech, Inc. - Recent Pipeline Updates, 2014
ProteoTech, Inc. - Dormant Developmental Projects,2014

List of Figures
ProteoTech, Inc. - Pipeline by Top 10 Indication, 2014
ProteoTech, Inc. - Pipeline by Stage of Development, 2014
ProteoTech, Inc. - Monotherapy Products in Pipeline, 2014
ProteoTech, Inc. - Pipeline by Top 10 Target, 2014
ProteoTech, Inc. - Pipeline by Top 10 Route of Administration, 2014
ProteoTech, Inc. - Pipeline by Top 10 Molecule Type, 2014
ProteoTech, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll